To join this class action, please complete the following Questionnaire.  Questionnaire & Fee Agreement Oklahoma City, OK (July 21, 2021) – On March 8, 2021, ClearBalance was a victim of a phishing attack. However, the security breach was not identified until April 26, 2021. The investigation into the breach revealed that cybercriminals were able to access the following highly confidential information: Names, tax IDs, Social Security numbers, dates of birth, government-issued ID numbers, telephone numbers, healthcare account numbers, balance amounts, dates of service, ClearBalance loan numbers and balances, personal banking information, clinical information, health insurance information, and full-face photographic images. […]

If you purchased Clover Health Investments, Corp. shares prior to February 4, 2021, and wish to join this litigation as a potential lead plaintiff, please complete the following Investor Certification The law firm of Federman & Sherwood has initiated an investigation into Clover Health Investments, Corp. [NASDAQ:  CLOV] (“CLOV”) with respect to possible violations of federal securities laws. On January 7, 2021, Clover merged with SPAC Social Capital Hedosphia Holdings Corp. III and began to trade under the symbol CLOV.  On February 4, 2021, Hindenburg Research published a report about CLOV titled “Clover Health: How the “King of SPACs” Lured Retail […]

If you are a job applicant, current or former employee or business partner of Belden, Inc. (“Belden”) (NYSE: BDC), or a current or former employee of one of its subsidiaries, including Grass Valley USA, LLC, who received a Notice of Data Breach and wish to join this litigation as a potential lead plaintiff, please complete the attached documents (click here) and return to our office by mail, email or facsimile. The law firm of Federman & Sherwood has initiated an investigation into Belden with respect to possible violations of state and federal consumer laws for a data breach incident that […]

If you purchased Sequential Brands Group, Inc. shares prior to December 11, 2020, and wish to join this litigation as a potential lead plaintiff, please complete the following Investor Certification http://www.federmanlaw.com/wp-content/uploads/2020/12/InvestCertSQBGFinal.pdf The law firm of Federman & Sherwood has initiated an investigation into Sequential Brands Group, Inc. [NASDAQ:  SQBG] (“Sequential”) with respect to possible violations of federal securities laws. On December 11, 2020, the U.S. Securities and Exchange Commission (“SEC”) issued a press release announcing that the “SEC Charges Sequential Brands Group Inc. with Deceiving Investors by Failing to Timely Impair Goodwill[.]” Specifically, the press release stated that “[a]s alleged, by […]

Oklahoma City, OK (November 3, 2020) – Investors who lost more than $100,000 (US) in Luckin Coffee Inc. (OTC Pink:  LKNCY) should consider contacting Federman & Sherwood if interested in recovering their losses. Luckin admitted that it committed financial fraud and was recently, along with affiliates, fined for engaging in sales fraud with more penalties possible. Allegations are based on Luckin having issued misrepresentations that may have had the effect of artificially inflating its stock price between May 17, 2019 through April 2, 2020, inclusive. In addition investor who bought in the Company’s public offering conducted on or around May […]

Oklahoma City, OK (October 1, 2020) – The law firm of Federman & Sherwood has initiated an investigation into cbdMD, Inc. [NYSE:  YCBD], and its subsidiary CBD Industries, LLC relating to a data breach announced by the Company. cbdMD is a producer and distributor of cannabidol (CBD) products. cbdMD, Inc. revealed that its e-commerce platform underlying their online retail sales webpage, cbdmd.com, was modified to include malicious code.  This malicious code created a risk that customers’ personal information was wrongfully acquired by third parties.  The personal information at risk could include your name, email address, billing address, credit or debit […]

Oklahoma City, OK (September 23, 2020) – The law firm of Federman & Sherwood initiates an investigation into Long & Foster Companies or one its subsidiaries:  Prosperity home Mortgage, LLC; Fonville Morisey Companies, Long & Foster Insurance, Long & Foster Real Estate, RGS Title, LLC, Sage Title Group, LLC, Settlement Professionals LLC or Mid-States Title Insurance Agency, Inc. relating to a ransomware attack and data breach on August 22, 2020.  An investigation was completed and it was determined that personal information, including name, address, telephone number, date of birth, Social Security number, W-2 details and bank information may have been […]

Oklahoma City, OK (August 25, 2020) – The law firm of Federman & Sherwood initiates an investigation into Filters Fast, LLC relating to malicious code being added to Filters Fast’s website.  Filters Fast was informed of a possible data security incident in late February 2020.  After an investigation by an outside expert forensics firm it was determined there was a breach of security.  The investigation revealed that attackers had succeeded in adding malicious code to FiltersFast’s website on July 15, 2019, which allowed unauthorized individuals to capture certain information during the checkout process.  The malicious code was removed on July […]

Oklahoma City, OK (July 17, 2020) – The law firm of Federman & Sherwood has initiated an investigation of a possible subscription scam into Learn Our History, the company that former Arkansas Governor Mike Huckabee co-founded in 2011. Learn our History was formed to make it fun for kids to learn American History.  The former Governor of Arkansas, talk show host and two-time presidential candidate’s firm said it is giving away its educational booklets – such as “The Kids Guide to President Trump” for free, or just $1 per item, in a “patriotic bundle” special.  But the offer is far […]

Oklahoma City, OK (May 8, 2020) – The law firm of Federman & Sherwood has initiated an investigation into CytoDyn Inc. [OTC: CYDY] and its officers and directors, with respect to possible violations of federal securities laws.  On April 27, 2020, CytoDyn, a late-stage biotechnology company, issued a press release indicating it had submitted a “Biologics License Application (“BLA”) to the U.S. Food and Drug Administration for Leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients.” On May 7, 2020, CytoDyn announced that its BLA for Leronlimab “will be considered completed after the clinical datasets are […]